Protagonist Therapeutics, Inc. (PTGX)

Protagonist Therapeutics Stock Forecast

Stock Price Forecast

According to 9 professional analysts, the 12-month price target for Protagonist Therapeutics stock ranges from a low of $51 to a high of $80. The average analyst price target of $67.11 forecasts a 20.51% increase in the stock price over the next year.

Price Target: $67.11 (+20.51%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$51	$67.11	$70	$80
Change	-8.42%	+20.51%	+25.70%	+43.65%

Analyst Ratings

The average analyst rating for Protagonist Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jan '25	Feb '25	Mar '25	Apr '25	May '25	Jun '25
Strong Buy	4	4	4	4	4	5
Buy	4	4	4	4	4	4
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	8	8	8	8	8	9

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Geoff Meacham Citigroup	Citigroup	Strong Buy Initiates $72	Strong Buy	Initiates	$72	+29.29%	Jun 17, 2025
Douglas Tsao HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $80	Strong Buy	Reiterates	$80	+43.65%	Jun 3, 2025
Douglas Tsao HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $80	Strong Buy	Reiterates	$80	+43.65%	May 19, 2025
Douglas Tsao HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $80	Strong Buy	Reiterates	$80	+43.65%	Apr 10, 2025
Yun Zhong Wedbush	Wedbush	Buy Reiterates $70	Buy	Reiterates	$70	+25.70%	Mar 28, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

83.56M

Decreased by -80.77%

from 434.43M

Revenue Next Year

122.95M

Increased by 47.15%

from 83.56M

EPS This Year

-1.98

from 4.23

EPS Next Year

-1.83

from -1.98

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	28.63M	27.36M	26.58M	60.00M	434.43M	83.56M	122.95M	218.25M
Revenue Growth	12,293.07%	-4.44%	-2.84%	125.73%	624.06%	-80.77%	47.15%	77.51%
EPS	-1.92	-2.71	-2.60	-1.39	4.23	-1.98	-1.83	-1.13
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	12	12	9

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	266.1M	302.4M	711.9M
Avg	83.6M	123.0M	218.3M
Low	27.7M	19.6M	46.1M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	-38.8%	261.9%	479.0%
Avg	-80.8%	47.1%	77.5%
Low	-93.6%	-76.5%	-62.5%

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	-1.23	-0.58	-0.17
Avg	-1.98	-1.83	-1.13
Low	-2.47	-3.64	-2.18

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.